{
    "title": "GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity prediction. (arXiv:2307.08989v1 [cs.LG])",
    "abstract": "Drug-target binding affinity prediction plays an important role in the early stages of drug discovery, which can infer the strength of interactions between new drugs and new targets. However, the performance of previous computational models is limited by the following drawbacks. The learning of drug representation relies only on supervised data, without taking into account the information contained in the molecular graph itself. Moreover, most previous studies tended to design complicated representation learning module, while uniformity, which is used to measure representation quality, is ignored. In this study, we propose GraphCL-DTA, a graph contrastive learning with molecular semantics for drug-target binding affinity prediction. In GraphCL-DTA, we design a graph contrastive learning framework for molecular graphs to learn drug representations, so that the semantics of molecular graphs are preserved. Through this graph contrastive framework, a more essential and effective drug repre",
    "link": "http://arxiv.org/abs/2307.08989",
    "context": "Title: GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity prediction. (arXiv:2307.08989v1 [cs.LG])\nAbstract: Drug-target binding affinity prediction plays an important role in the early stages of drug discovery, which can infer the strength of interactions between new drugs and new targets. However, the performance of previous computational models is limited by the following drawbacks. The learning of drug representation relies only on supervised data, without taking into account the information contained in the molecular graph itself. Moreover, most previous studies tended to design complicated representation learning module, while uniformity, which is used to measure representation quality, is ignored. In this study, we propose GraphCL-DTA, a graph contrastive learning with molecular semantics for drug-target binding affinity prediction. In GraphCL-DTA, we design a graph contrastive learning framework for molecular graphs to learn drug representations, so that the semantics of molecular graphs are preserved. Through this graph contrastive framework, a more essential and effective drug repre",
    "path": "papers/23/07/2307.08989.json",
    "total_tokens": 870,
    "translated_title": "GraphCL-DTA: 一种基于分子语义的图对比学习方法用于药物靶标结合亲和力预测",
    "translated_abstract": "药物靶标结合亲和力预测在药物研发的早期阶段起着重要作用，可以推断新药和新靶标之间相互作用的强度。然而，以往的计算模型在以下方面存在限制：药物表示的学习仅依赖于有监督数据，没有考虑分子图中所包含的信息。此外，大多数先前的研究倾向于设计复杂的表示学习模块，忽略了用于衡量表示质量的一致性。本研究提出了一种名为GraphCL-DTA的图对比学习方法，用于药物靶标结合亲和力预测。在GraphCL-DTA中，我们设计了一个图对比学习框架，用于学习药物表示，以保留分子图的语义。通过这个图对比学习框架，可以得到更本质和有效的药物表示。",
    "tldr": "GraphCL-DTA是一种使用分子语义进行药物靶标结合亲和力预测的图对比学习方法。通过设计图对比学习框架，可以学习到更本质和有效的药物表示。",
    "en_tdlr": "GraphCL-DTA is a graph contrastive learning method that uses molecular semantics for drug-target binding affinity prediction. By designing a graph contrastive learning framework, more essential and effective drug representations can be learned."
}